CI Trading Analysis - 10/30/2026 02:29 PM — TRU-SENTIMENT

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below.

• Cigna (CI) recently reaffirmed full-year adjusted EPS guidance amid stable U.S. healthcare enrollment trends, easing prior cost-ratio concerns.
• Managed care sector lifted by softer-than-expected regulatory rhetoric on Medicare Advantage reimbursement cuts.
• CI declared a quarterly dividend with ex-dividend date of December 3, 2026, yield roughly 2.09% per fundamentals.
• No major earnings catalyst before the next major options expiration (2026-11-20); steady operating backdrop expected.
• Low beta (0.13) suggests CI lags broad-market volatility, potentially attracting defensive rotation.

Context: Headlines reflect a stable fundamental backdrop with a near-term dividend event, which aligns with the bullish options flow and mild upward technical bias in the embedded data rather than any disruptive catalyst.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for CI:

• Trailing P/E: 12.30; Trailing EPS: $24.31 — low multiple vs typical healthcare peers, suggesting discounted valuation.
• Market Cap: $79,359,199,200.00; Shares Outstanding: 264,240,000.00.
• Dividend Yield: 2.09%; Dividend Rate: $6.24; Ex-Dividend Date: 2026-12-03.
• Beta: 0.13 (very low systematic risk); 52-Week Range: $239.51 to $316.27.
• Institutional Ownership: 63.51%; Average Volume: 1,445,000.00 shares.
• Historical Volatility: 25.97%; Fiscal Year End: 2025-12-01.
• PEG Ratio, Forward P/E, Forward EPS, Revenue Growth, Margins, ROE, Debt/Equity, FCF, Analyst Target: all null — not available in data.

Fundamentally, CI screens cheap on trailing earnings with defensive characteristics (low beta, dividend). The absence of growth/margin data prevents deeper quality assessment, but the low P/E and stable institutional base do not conflict with the constructive technical and sentiment picture.

Current Market Position

Current price per indicators (2026-10-29): $297.11. Daily history shows close on 2026-10-29 at $297.11 after intraday low $295.44 and high $300.90. Minute bars for 2026-10-29 to 2026-10-30 14:00 show open $300.84, drift to $299.11, then recovery to $300.52 by final bar — mild intraday dip and reclaim.

Intraday momentum: last 5 minute bars show higher lows ($299.27 → $299.73 → $300.11 → $300.52) with volume pickup to 10,301 at 14:00 — modest late-session bid.

Technical Analysis

• SMA alignment: 5 > 20 > 50 ($300.40 > $292.04 > $283.37) — bullish stack, no bearish cross.
• Price ($297.11) below SMA 5 but above SMA 20/50 — short-term cooling within uptrend.
• RSI 61.03: bullish-but-not-overbought momentum.
• MACD positive (6.24) above signal (4.99), histogram +1.25 — bullish momentum intact.
• Bollinger: price near mid ($292.04), well below upper ($317.56) — room to expand higher.
• 30-day range: high $316.26, low $262.85; price at ~56% of range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (delta 40-60 only):

Call Volume: $249,400.00 (70.7%) Put Volume: $103,130.00 (29.3%) Total: $352,530.00

• Sentiment: Bullish (calls dominate directional conviction).
• 147 call contracts vs 89 put contracts; 23 call trades vs 9 put trades.
• Pure directional positioning skews bullish into 2026-11-20 expiration.
• No divergence: technicals (SMA stack, MACD) and sentiment both lean bullish; minor price softness below SMA 5 not contradicted by flow.

Key Price Levels (Observational Only)